“A Randomized study of sofosbuvir plus ribavirin with and without PEG interferon alpha 2b in treatment of hepatitis C genotype 3 infection: Real life data from a Tertiary Care Center”, Int J of Biomed & Adv Res, vol. 9, no. 3, pp. 91–95, Apr. 2018, doi: 10.7439/ijbar.v9i3.4673.